Legacy Education's Q2 revenue up 40.7%, beats estimates

Reuters
02/13
<a href="https://laohu8.com/S/LGCY">Legacy Education</a>'s <a href="https://laohu8.com/S/QTWO">Q2</a> revenue up 40.7%, beats estimates

Overview

  • Career education provider's fiscal Q2 revenue rose 40.7%, beating analysts' expectations

  • Adjusted EBITDA beat estimates

  • Company saw a 49.4% increase in new student starts, boosting revenue

Outlook

  • Legacy Education sees continued growth potential as it scales its healthcare education platform

  • Company anticipates further demand acceleration for healthcare programs

Result Drivers

  • ENROLLMENT GAINS - Legacy Education reported a 49.4% increase in new student starts, driving revenue growth

  • HEALTHCARE PROGRAM DEMAND - CEO LeeAnn Rohmann stated that demand for healthcare programs continues to accelerate

  • EXPENSE INCREASES - Educational services and general administrative expenses rose due to increased staffing and marketing

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$19.20 mln

$17.56 mln (3 Analysts)

Q2 EPS

$0.15

Q2 Net Income

$2 mln

Q2 Adjusted EBITDA

Beat

$3 mln

$2.64 mln (3 Analysts)

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the schools, colleges & universities peer group is "buy"

  • Wall Street's median 12-month price target for Legacy Education Inc is $13.00, about 23.8% above its February 11 closing price of $10.50

Press Release: ID:nPn24fwtSa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10